Medicine and Dentistry
Uterine Fibroid
100%
Angioleiomyoma
67%
Extracellular Matrix
37%
Signal Transduction
36%
Fibrosis
23%
Activin A
19%
Phytochemical
14%
Growth Factor
14%
Disease
13%
Myometrium
12%
Epigallocatechin Gallate
11%
Mechanotransduction
11%
Growth, Development and Aging
10%
Combination Therapy
10%
Neoplasm
10%
Myostatin
9%
Simvastatin
9%
Gynecologic Disease
9%
Tranilast
9%
In Vitro
7%
Fibronectin
7%
Gene Expression
7%
Catenin
7%
Benign Tumor
7%
Pathophysiology
7%
Cell Proliferation
7%
Progesterone
6%
Angiogenesis
6%
Tissue Repair
6%
microRNA
5%
Mediator
5%
Versican
5%
Hippo Signaling
5%
Protein Expression
5%
Keyphrases
Uterine Fibroids
29%
Leiomyoma
28%
Leiomyoma Cells
25%
Activin
23%
Uterine Leiomyoma
22%
Myometrial Cells
19%
Fibroids
15%
Uterine Leiomyoma Cell
14%
Growth Factors
14%
Signaling Pathway
11%
MicroRNA
9%
Myostatin
9%
Extracellular Matrix
9%
Tranilast
9%
Simvastatin
9%
Antifibrotic
8%
Gene Expression
7%
Abnormal Uterine Bleeding
7%
Gynecological Diseases
7%
Therapeutic Potential
7%
Fibronectin
7%
Tumor
7%
Pathophysiology
7%
Fibrosis
6%
Future Therapeutics
6%
Tissue Repair
6%
Myometrial
6%
Myometrium
6%
Inflammation
6%
Ulipristal Acetate
6%
Gynaecological Pathology
5%
Estrogen
5%
Medical Treatment
5%
Tissue Fibrosis
5%
Mechanical Signals
5%
Matrix Expression
5%
Fibrotic Disorders
5%
Selective Progesterone Receptor Modulator
5%
Mechanotransduction
5%
Versican
5%
Pharmacology, Toxicology and Pharmaceutical Science
Uterus Myoma
65%
Leiomyoma
37%
Fibrosis
23%
Activin A
11%
microRNA
10%
Disease
10%
Growth Factor
9%
Combination Therapy
9%
Strawberry
9%
Simvastatin
9%
Neoplasm
7%
Reactive Oxygen Metabolite
7%
Epigallocatechin Gallate
6%
Progesterone
6%
Pathophysiology
6%
Tissue Repair
6%
Inflammation
6%
Phytochemical
5%
Malignant Neoplasm
5%
Vitamin D
5%
Progesterone Receptor Modulator
5%
